AAAAAA
Results: 1-25/42
Authors:
TURNER JG
TAN J
CRUCIAN BE
SULLIVAN DM
BALLESTER OF
DALTON WS
YANG NS
BURKHOLDER JK
YU H
Citation: Jg. Turner et al., BROADENED CLINICAL UTILITY OF GENE GUN-MEDIATED, GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR CDNA-BASED TUMOR-CELL VACCINES AS DEMONSTRATED WITH A MOUSE MYELOMA MODEL, Human gene therapy, 9(8), 1998, pp. 1121-1130
Authors:
BALLESTER OF
CORRADO C
VESOLE D
Citation: Of. Ballester et al., MULTIPLE-MYELOMA IN THE ELDERLY, Annals of oncology, 9, 1998, pp. 10-10
Authors:
BALLESTER OF
Citation: Of. Ballester, MULTIPLE-MYELOMA - AGE-RELATED-CHANGES IN IMMUNE FUNCTION AND CYTOKINE EXPRESSION IN THE PATHOGENESIS OF THE DISEASE, Annals of oncology, 9, 1998, pp. 59-59
Authors:
FIELDS KK
ELFENBEIN GJ
PERKINS JB
BALLESTER OF
GOLDSTEIN SC
HEIMENZ JW
SAEZ RA
SULLIVAN DM
PARTYKA JS
KRONISH LA
Citation: Kk. Fields et al., DEFINING THE ROLE OF NOVEL HIGH-DOSE CHEMOTHERAPY REGIMENS FOR THE TREATMENT OF HIGH-RISK BREAST-CANCER, Seminars in oncology, 25(2), 1998, pp. 1-6
Authors:
MAURTUA MA
MOSCINSKI LC
MESSINA J
MILLER L
BALLESTER OF
Citation: Ma. Maurtua et al., TYPE-III HYPERSENSITIVITY REACTION WITH THE USE OF INTERFERON-ALPHA, American journal of hematology, 55(1), 1997, pp. 53-54
Authors:
BALLESTER OF
TUMMALA R
JANSSEN WE
FIELDS KK
HIEMENZ JW
GOLDSTEIN SC
PERKINS JB
SULLIVAN DM
ROSEN R
SACKSTEIN R
ZORSKY P
SAEZ R
ELFENBEIN GJ
Citation: Of. Ballester et al., HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH MULTIPLE-MYELOMA AND RENAL-INSUFFICIENCY, Bone marrow transplantation, 20(8), 1997, pp. 653-656
Authors:
CRUCIAN BE
MOSCINSKI LC
ANDROLEWICZ M
BALLESTER OF
WIDEN RH
YU H
Citation: Be. Crucian et al., ASSESSMENT OF INTRACELLULAR TAP-1 AND TAP-2 IN CONJUNCTION WITH SURFACE MHC CLASS-I IN PLASMA-CELLS FROM PATIENTS WITH MULTIPLE-MYELOMA, British Journal of Haematology, 98(2), 1997, pp. 426-432
Authors:
BALLESTER OF
MOSCINSKI LC
FIELDS KK
HIEMENZ JW
ZORSKY PE
GOLDSTEIN SC
SABA HI
SPIERS ASD
KRONISH L
SULLIVAN P
ELFENBEIN GJ
Citation: Of. Ballester et al., DEXAMETHASONE, CYCLOPHOSPHAMIDE, IDARUBICIN AND ETOPOSIDE (DC-IE) - ANOVEL, INTENSIVE INDUCTION CHEMOTHERAPY REGIMEN FOR PATIENTS WITH HIGH-RISK MULTIPLE-MYELOMA, British Journal of Haematology, 96(4), 1997, pp. 746-748
Authors:
MOSCINSKI LC
BALLESTER OF
SABA HI
BLAIR P
Citation: Lc. Moscinski et al., IL-6 RECEPTOR AND ADHESION PROTEIN PROFILES AS PROGNOSTIC FEATURES INMULTIPLE-MYELOMA, Blood, 90(10), 1997, pp. 2343-2343
Authors:
AGALIOTIS DP
BALLESTER OF
MATTOX T
HIEMENZ JW
FIELDS KK
ZORSKY PE
GOLDSTEIN SC
PERKINS JB
ROSEN RM
ELFENBEIN GJ
Citation: Dp. Agaliotis et al., NEPHROTOXICITY OF HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE IN ADULTS UNDERGOING AUTOLOGOUS STEM-CELL TRANSPLANTATION/, The American journal of the medical sciences, 314(5), 1997, pp. 292-298
Authors:
BALLESTER OF
AGALIOTIS DP
HIEMENZ JW
JANSSEN WE
FIELDS KK
ZORKSY PE
GOLDSTEIN SC
PERKINS JB
ELFENBEIN GJ
Citation: Of. Ballester et al., PHASE I-II STUDY OF HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES - TOXICITIES AND HEMATOPOIETIC RECOVERY, Bone marrow transplantation, 18(1), 1996, pp. 9-14
Authors:
MOSCINSKI LC
BALLESTER OF
SABA HI
BLAIR P
Citation: Lc. Moscinski et al., MATURE PLASMA-CELLS FROM ALL PATIENTS WITH MULTIPLE-MYELOMA POSSESS ADHESION PROTEINS, BUT WITH VARIABLE PATTERNS OF EXPRESSION, Blood, 88(10), 1996, pp. 1562-1562
Authors:
VESCIO RA
SCHILLER GJ
STEWART AK
ANDERSON KC
DIPERSIO JF
NOGA SJ
BALLESTER OF
RUGO H
FREYTES CO
WU CH
HAN EJ
CAO J
BELSON DJ
BERENSON JR
Citation: Ra. Vescio et al., QUANTITATIVE ASSESSMENT OF MYELOMA PERIPHERAL-BLOOD AND BONE-MARROW TUMOR BURDEN IN PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION, Blood, 88(10), 1996, pp. 2551-2551
Authors:
FIELDS KK
ELFENBEIN GJ
LAZARUS HM
COOPER BW
PERKINS JB
CREGER RJ
BALLESTER OF
HIEMENZ JH
JANSSEN WE
ZORSKY PE
Citation: Kk. Fields et al., MAXIMUM-TOLERATED DOSES OF IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE GIVEN OVER 6 DAYS FOLLOWED BY AUTOLOGOUS STEM-CELL RESCUE - TOXICITY PROFILE, Journal of clinical oncology, 13(2), 1995, pp. 323-332
Authors:
PERKINS JB
ELFENBEIN GJ
JANSSEN WE
FIELDS KK
BALLESTER OF
HIEMENZ JW
ZORSKY PE
GOLDSTEIN SC
Citation: Jb. Perkins et al., LACK OF DIFFERENCE IN RATE OF HEMATOPOIETIC RECOVERY AFTER BONE-MARROW AND PERIPHERAL-BLOOD STEM-CELL INFUSION VERSUS PERIPHERAL-BLOOD STEM-CELLS ALONE, Experimental hematology, 23(8), 1995, pp. 761-761
Authors:
BALLESTER OF
MOSCINSKI LC
FARMELO MJ
MULLEN MG
HILL B
Citation: Of. Ballester et al., CLINICAL-SIGNIFICANCE OF INTERLEUKIN-6 AND SOLUBLE INTERLEUKIN-6 RECEPTOR EXPRESSION IN THE BONE-MARROW OF PATIENTS WITH PLASMA-CELL DISORDERS, Blood, 86(10), 1995, pp. 240-240
Authors:
JANSSEN WE
HIEMENZ JW
FIELDS KK
ZORSKY PE
BALLESTER OF
GOLDSTEIN SC
SMILEE R
KRONISH L
ELFENBEIN GJ
Citation: We. Janssen et al., PERIPHERAL-BLOOD STEM-CELLS DO NOT ALWAYS PRODUCE FASTER ENGRAFTMENT THAN BONE-MARROW IN AUTOTRANSPLANTATION, Experimental hematology, 22(8), 1994, pp. 765-765
Authors:
FIELDS KK
ELFENBEIN GJ
PERKINS JP
BALLESTER OF
HIEMENZ JW
ZORSKY PE
Citation: Kk. Fields et al., EVENT-FREE SURVIVAL IN BREAST-CANCER PATIENTS TREATED WITH HIGH-DOSE IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE AND AUTOLOGOUS STEM-CELL RESCUE- ANALYSIS OF RISK-FACTORS, Experimental hematology, 22(8), 1994, pp. 779-779
Authors:
ELFENBEIN GJ
FIELDS KK
PERKINS JB
BALLESTER OF
GOLDSTEIN SC
HIEMENZ JW
ZORSKY PE
Citation: Gj. Elfenbein et al., TIME TO RELAPSE AFTER HIGH-DOSE CHEMOTHERAPY WITH 2 NOVEL REGIMENS FOR METASTATIC BREAST-CANCER, Experimental hematology, 22(8), 1994, pp. 780-780
Authors:
PERKINS JB
CREMERS KA
FIELDS KK
JANSSEN WE
BALLESTER OF
GOLDSTEIN SC
HIEMENZ JW
ZORSKY PE
ELFENBEIN GJ
Citation: Jb. Perkins et al., DIFFERENCES IN ENGRAFTMENT RATE BETWEEN 2 GROUPS OF BREAST-CANCER PATIENTS TREATED WITH THE SAME HIGH-DOSE CHEMOTHERAPY REGIMEN - POTENTIALCONTRIBUTING FACTORS FOR HEMATOPOIETIC RECOVERY, Experimental hematology, 22(8), 1994, pp. 782-782
Authors:
BALLESTER OF
AGALIOTIS DP
JANSSEN WE
FIELDS KK
HIEMENZ JW
ZORSKY PE
GOLDSTEIN SC
ELFENBEIN GJ
Citation: Of. Ballester et al., PATTERNS OF PLATELET RECOVERY AFTER BUSULFAN CYCLOPHOSPHAMIDE AND PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH HEMATOLOGICALMALIGNANCIES/, Experimental hematology, 22(8), 1994, pp. 782-782
Authors:
MOSCINSKI LC
BALLESTER OF
Citation: Lc. Moscinski et Of. Ballester, RECENT PROGRESS IN MULTIPLE-MYELOMA, Hematological oncology, 12(3), 1994, pp. 111-123
Authors:
FIELDS KK
ELFENBEIN GJ
PERKINS JB
JANSSEN WE
BALLESTER OF
HIEMENZ JW
ZORSKY PE
KRONISH LE
FOODY MC
Citation: Kk. Fields et al., HIGH-DOSE IFOSFAMIDE CARBOPLATIN/ETOPOSIDE - MAXIMUM TOLERABLE DOSES,TOXICITIES, AND HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS STEM-CELL REINFUSION/, Seminars in oncology, 21(5), 1994, pp. 86-92
Authors:
BALDUCCI L
BENSON K
LYMAN GH
SANDERSON R
FIELDS K
BALLESTER OF
ELFENBEIN GJ
Citation: L. Balducci et al., COST-EFFECTIVENESS OF WHITE CELL-REDUCTION FILTERS IN TREATMENT OF ADULT ACUTE MYELOGENOUS LEUKEMIA - REPLY, Transfusion, 34(4), 1994, pp. 359-359
Authors:
JANSSEN WE
PERKINS J
HIEMENZ JW
FIELDS KK
ZORSKY PE
BALLESTER OF
GOLDSTEIN SC
SMILEE R
KRONISH L
ELFENBEIN GJ
Citation: We. Janssen et al., GRANULOCTE RECOVERY IS NOT DIFFERENT FOLLOWING AUTOTRANSPLANT WITH G-CSF PRIMED BONE-MARROW OR G-CSF MOBILIZED PERIPHERAL-BLOOD STEM-CELLS, Blood, 84(10), 1994, pp. 10000095-10000095